EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 23 září 2021. Database contains 4621 unique substances/entries.
Filter the list

204-811-2
126-91-0
Skin Sens. 1B
The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700°C (1292°F)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.
266-012-5
65996-78-3
Carc. 1B; Muta. 1B
The volatile organic liquid condensed from the gas evolved in the low-temperature (less than 700°C (1292°F)) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.
292-635-7
90641-11-5
Carc. 1B; Muta. 1B
A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20°C to 135°C (58°F to 275°F).
232-453-7
8032-32-4
Carc. 1B; Muta. 1B; Asp. Tox. 1
201-134-4
78-70-6
Skin Sens. 1B
200-401-2
58-89-9
Acute Tox. 3; Acute Tox. 4; STOT RE 2; Lact.
206-356-5
330-55-2
Repr. 1B; Carc. 2; Acute Tox. 4; STOT RE 2
-
-
B Bacteria and similar species
-
-
B Bacteria and similar species
231-102-5
7439-93-2
Water-react. 1; Skin Corr. 1B
BLUE 14 52 200
411-140-0
125328-86-1
Eye Dam. 1; Skin Sens. 1
411-690-1
111337-53-2
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
BIS TRIFLUOROMETHANE SULFONIMIDE LITHIUM; FLUORAD BRAND LITHIUM TRIFLUOROMETHANESULPHONIMIDE HQ-115
415-300-0
90076-65-6
Acute Tox. 3; STOT RE 2; Skin Corr. 1B
212-737-7
865-34-9
Self-heat. 1; Skin Corr. 1B
620-400-4
12031-65-1
Carc. 1A; STOT RE 1; Skin Sens. 1
249-644-6
29457-72-5
Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
-
-
Skin Sens. 1
ACID RED FC 70013
414-250-7
149564-66-9
Acute Tox. 4; Eye Dam. 1
429-730-1
193562-37-7
Eye Dam. 1; Skin Sens. 1
REACTIVE BLUE FC 05 717
401-560-2
108624-00-6
Skin Sens. 1
-
-
P Parasites
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.
278-011-7
74869-21-9
Carc. 1B
A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100°F (23cSt at 40°C).
297-474-6
93572-43-1
Carc. 1B
A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40°C. It contains a relatively large proportion of saturated hydrocarbons.
276-737-9
72623-86-0
Carc. 1B
A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produces a finished oil with a viscosity in the order of 17cSt to 23cSt at 40°C (104°F).
309-875-6
101316-70-5
Carc. 1B
295-423-2
92045-42-6
Carc. 1B
307-034-8
97488-95-4
Carc. 1B
A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370°C to 550°C (698°F to 1022°F).
305-594-8
94733-15-0
Carc. 1B
A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370°C to 550°C (698°F to 1022°F).
305-595-3
94733-16-1
Carc. 1B
A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40°C (104°F).
309-876-1
101316-71-6
Carc. 1B
A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40°C. It contains a relatively large proportion of saturated hydrocarbons.
276-736-3
72623-85-9
Carc. 1B
A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40°C. It contains a relatively large proportion of saturated hydrocarbons.
276-738-4
72623-87-1
Carc. 1B
A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40°C (104°F).
309-877-7
101316-72-7
Carc. 1B
A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100°C (212°F).
309-874-0
101316-69-2
Carc. 1B
295-424-8
92045-43-7
Carc. 1B
A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.
278-012-2
74869-22-0
Carc. 1B
CGA 184699
410-690-9
103055-07-8
Skin Sens. 1
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
202-987-5
101-90-6
Carc. 1B; Muta. 2; Acute Tox. 3; Acute Tox. 4; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1
203-577-9
108-39-4
Acute Tox. 3; Skin Corr. 1B
404-150-1
17092-80-7
Skin Irrit. 2
202-729-1
99-09-2
Acute Tox. 3; STOT RE 2
203-584-7
108-45-2
Muta. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
208-790-0
541-69-5
Muta. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
203-583-1
108-44-1
Acute Tox. 3; STOT RE 2
247-722-4
26471-62-5
Carc. 2; Acute Tox. 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
203-576-3
108-38-3
Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
F Fungi
-
-
F Fungi
-
-
Pyr. Liq. 1; Water-react. 1; Skin Corr. 1B
413-360-2
164058-21-3
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
241-022-2
16949-65-8
Acute Tox. 3
235-023-7
12057-74-8
Water-react. 1; Acute Tox. 2; Acute Tox. 3; Acute Tox. 1
231-104-6
7439-95-4
Water-react. 1; Pyr. Sol. 1
231-104-6
7439-95-4
Flam. Sol. 1; Water-react. 2; Self-heat. 1
-
37296-97-2
STOT RE 2
-
-
Eye Dam. 1
417-280-9
30785-74-1
Eye Dam. 1
-
-
Skin Sens. 1
209-322-8
569-64-2
Repr. 2; Acute Tox. 4; Eye Dam. 1
219-441-7
2437-29-8
Repr. 2; Acute Tox. 4; Eye Dam. 1
204-497-7
121-75-5
Acute Tox. 4; Skin Sens. 1
203-742-5
110-16-7
Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
203-571-6
108-31-6
Acute Tox. 4; STOT RE 1; Skin Corr. 1B; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1A
203-703-2
109-77-3
Acute Tox. 3
616-995-5
8018-01-7
Carc. 2; Repr. 1B; STOT RE 2; Skin Sens. 1
235-654-8
12427-38-2
Repr. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
215-202-6
1313-13-9
Acute Tox. 4
232-089-9
7785-87-7
STOT RE 2
239-924-6
15825-70-4
Unst. Expl.
239-924-6
15825-70-4
Expl. 1.1
-
-
P Parasites
-
-
P Parasites
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
202-360-6
94-74-6
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
246-831-4
25319-90-8
Acute Tox. 4
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
219-993-9
2595-54-2
Acute Tox. 3
221-106-5
3006-10-8
Skin Corr. 1; Eye Dam. 1
-
-
Acute Tox. 4; Eye Dam. 1
240-539-0
16484-77-8
Acute Tox. 4; Eye Dam. 1
205-275-2
137-05-3
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
219-634-6
2487-01-6
Acute Tox. 3; Acute Tox. 4
277-543-7
73581-79-0
Eye Irrit. 2; Skin Irrit. 2
204-987-0
130-37-0
Eye Irrit. 2; Skin Irrit. 2
201-123-4
78-57-9
Acute Tox. 4
432-140-7
110235-47-7
Carc. 2
213-447-3
950-10-7
Acute Tox. 1; Acute Tox. 2
205-769-8
150-76-5
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
217-991-2
2032-65-7
Acute Tox. 3
231-106-7
7439-97-6
Repr. 1B; Acute Tox. 2; STOT RE 1
231-299-8
7487-94-7
Muta. 2; Repr. 2; Acute Tox. 2; STOT RE 1; Skin Corr. 1B
211-057-8
628-86-4
Expl. 1.1; Acute Tox. 3; STOT RE 2
211-057-8
628-86-4
Unst. Expl.; Acute Tox. 3; STOT RE 2
203-604-4
108-67-8
Flam. Liq. 3; STOT SE 3
600-533-4
104206-82-8
Repr. 2; STOT RE 2
-
852403-68-0
Repr. 2; Lact.; STOT RE 2
604-167-6
139968-49-3
Repr. 2; Lact.; STOT RE 2
-
-
Acute Tox. 4
260-979-7
57837-19-1
Acute Tox. 4; Skin Sens. 1
615-135-6
70630-17-0
Acute Tox. 4; Eye Dam. 1
205-293-0
137-42-8
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
255-349-3
41394-05-2
Acute Tox. 4
266-583-0
67129-08-2
Skin Sens. 1B; Carc. 2
603-031-3
125116-23-6
Repr. 2; Acute Tox. 4
630-448-8
62610-77-9
Acute Tox. 4; Skin Sens. 1
201-204-4
79-41-4
Acute Tox. 4; Skin Corr. 1A
204-817-5
126-98-7
Flam. Liq. 2; Acute Tox. 3; Skin Sens. 1
233-606-0
10265-92-6
Acute Tox. 2; Acute Tox. 3
200-812-7
74-82-8
Flam. Gas 1; Press. Gas
200-898-6
75-75-2
Skin Corr. 1B
200-822-1
74-93-1
Flam. Gas 1; Press. Gas; Acute Tox. 3
200-659-6
67-56-1
Flam. Liq. 2; Acute Tox. 3; STOT SE 1
202-905-8
100-97-0
Flam. Sol. 2; Skin Sens. 1
213-449-4
950-37-8
Acute Tox. 2; Acute Tox. 4
240-815-0
16752-77-5
Acute Tox. 2
210-894-6
625-45-6
Repr. 1B; Acute Tox. 4; Skin Corr. 1B
GR138766X
415-670-3
78850-37-0
Eye Dam. 1
445-990-9
376588-17-9
Skin Sens. 1
HALOXYFOP R-(+)-ME HERBICIDAL CHEMICAL
406-250-0
72619-32-0
Acute Tox. 4
411-950-4
96562-58-2
Eye Dam. 1
241-420-6
17392-83-5
Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
248-704-9
27871-49-4
Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
208-930-0
2155-30-8;547-64-8
Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
208-930-0
2155-30-8;547-64-8
Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
432-350-9
81752-87-6
Skin Irrit. 2
220-815-7
2905-69-3
Acute Tox. 4; STOT SE 3
2-NITROBENZYLIDENE METHYL ESTER; BAY O 2787
400-650-9
39562-27-1
Skin Sens. 1
405-270-7
39562-17-9
Skin Sens. 1
442-860-3
87333-22-0
Skin Sens. 1
416-240-8
155522-12-6
Skin Sens. 1
421-220-7
144740-59-0
Skin Sens. 1
420-940-9
15768-07-7
Eye Irrit. 2; Skin Irrit. 2
443-120-2
393509-79-0
Eye Dam. 1
404-130-2
105560-93-8
Eye Dam. 1; Skin Sens. 1
620-362-9
1918-18-9
Acute Tox. 4
403-270-1
6386-39-6
Acute Tox. 4
411-040-7
97101-46-7
Acute Tox. 4; Skin Sens. 1
250-366-2
30864-28-9
Acute Tox. 4; Skin Sens. 1
431-720-7
90886-53-6
Skin Corr. 1B; Acute Tox. 4
425-190-6
119916-05-1
STOT RE 2
410-550-7
79277-18-2
STOT RE 2; Resp. Sens. 1; Skin Sens. 1
402-050-2
-
Skin Sens. 1
410-310-1
70264-94-7
Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
414-080-3
117291-73-3
Acute Tox. 4
201-185-2
79-20-9
Flam. Liq. 2; Eye Irrit. 2; STOT SE 3
203-299-8
105-45-3
Eye Irrit. 2
403-230-3
77402-05-2
Carc. 1B; Muta. 1B; Skin Corr. 1B; Skin Sens. 1
401-890-7
77402-03-0
Carc. 1B; Muta. 1B; Acute Tox. 4; Eye Irrit. 2
202-500-6
96-33-3
Flam. Liq. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
202-501-1
96-34-4
Flam. Liq. 3; Acute Tox. 3; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
201-187-3
79-22-1
Flam. Liq. 2; Acute Tox. 2; Acute Tox. 4; Skin Corr. 1B
203-481-7
107-31-3
Flam. Liq. 1; Acute Tox. 4; Eye Irrit. 2; STOT SE 3
200-819-5
74-88-4
Carc. 2; Acute Tox. 4; Acute Tox. 3; STOT SE 3; Skin Irrit. 2
210-866-3
624-83-9
Flam. Liq. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; Resp. Sens. 1; Skin Sens. 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
209-132-5
556-61-6
Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1
201-297-1
80-62-6
Flam. Liq. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
413-040-2
149850-30-6
Skin Sens. 1
414-460-9
105726-67-8
Acute Tox. 4
209-060-4
554-12-1
Flam. Liq. 2; Acute Tox. 4
204-317-7
119-36-8
Repr. 2; Acute Tox. 4; Skin Sens. 1B
420-670-1
37443-42-8
Eye Dam. 1
203-475-4
107-25-5
Flam. Gas 1; Press. Gas
401-340-6
83055-99-6
Skin Sens. 1
236-035-5
13108-52-6
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
419-010-5
112941-26-1
Acute Tox. 4; Eye Irrit. 2
BETA-METHOXYACRYLSÄURE METHYLESTER
412-900-4
5788-17-0
Skin Sens. 1
435-500-1
152460-07-6
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
209-765-7
592-62-1
Carc. 1B; Repr. 1B
246-910-3
25376-45-8
Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1
203-624-3
108-87-2
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3
228-652-3
6317-18-6
Acute Tox. 2; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1
247-714-0
26447-40-5
Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
429-320-2
24748-23-0
Org. Perox. B; Asp. Tox. 1; Skin Irrit. 2; Skin Sens. 1
200-471-4
60-34-4
Carc. 1B
204-064-2
115-09-3
Carc. 2; Repr. 1A; Lact.; Acute Tox. 2; STOT RE 1
418-400-2
1031-15-8
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
214-446-0
1129-41-5
Acute Tox. 4
244-209-7
21087-64-9
Acute Tox. 4
232-095-1
7786-34-7
Acute Tox. 1; Acute Tox. 2
206-249-3
315-18-4
Acute Tox. 2; Acute Tox. 4
-
-
F Fungi
-
-
Acute Tox. 4
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
-
1314-04-1
Carc. 1A; Muta. 2; STOT RE 1; Skin Sens. 1
show/hide
Glass Wool ecnumber: - | casnumber: 308066-92-4
Glass, oxide, chemicals
This category encompasses the various chemical substances manufactured in the production of inorganic glasses. For purposes of this category, 'glass' is defined as an amorfous, inorganic, transparent, translucent or opaque material traditionally formed by fusion of sources of silica with a flux, such as an alkali-metal carbonate, boron oxide, etc. and a stabilizer, into a mass which is cooled to a rigid condition without crystallization in the case of transparent or liquid-phase separated glass or with controlled crystallization in the case of glass-ceramics. The category consists of the various chemical substances, other than by-products or impurities, which are formed during the production of various glasses and concurrently incorporated into a glass mixture. All glasses contain one or more of these substances, but few, if any, contain all of them. The elements listed below are principally present as components of oxide systems but some may also be present as halides or chalcogenides, in multiple oxidation states, or in more complex compounds. Trace amounts of other oxides or chemical compounds may be present. Oxides of the first seven elements listed* comprise more than 95 percent, by weight, of the glass produced. @Aluminium*@Lead@Boron*@Lithium@Calcium*@Manganese@Magnesium*@Molybdenum@Potassium*@Neodymium@Silicon*@Nickel@Sodium*@Niobium@Antimony@Nitrogen@Arsenic@Phosphorus@Barium@Praseodymium@Bismuth@Rubidium@Cadmium@Selenium@Carbon@Silver@Cerium@Strontium@Cesium@Sulfur@Chromium@Tellurium@Cobalt@Tin@Copper@Titanium@Germanium@Tungsten@Gold@Uranium@Holmium@Vanadium@Iron@Zinc@Lanthanum@Zirconium
ecnumber: 266-046-0 | casnumber: 65997-17-3
-
-
Carc. 2
206-742-3
371-86-8
STOT SE 1
215-293-2
1319-77-3
Acute Tox. 3; Skin Corr. 1B
420-480-9
158570-99-1
Skin Irrit. 2; Skin Sens. 1
218-661-0
2212-67-1
Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1
268-585-7
68130-36-9
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1
-
12673-58-4
Carc. 1A; STOT RE 1; Skin Sens. 1
238-034-5
14177-55-0
Carc. 1A; STOT RE 1; Skin Sens. 1
215-204-7
1313-27-5
Carc. 2; Eye Irrit. 2; STOT SE 3
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
415-180-1
773058-82-5
Acute Tox. 4; Eye Dam. 1

export-type